REGISTERED NUMBER: 12655456 (England and Wales)

AVAS HOLDINGS LIMITED

GROUP STRATEGIC REPORT,

REPORT OF THE DIRECTORS AND

AUDITED

CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

Page

Company Information

1

Group Strategic Report

2

Report of the Directors

5

Independent Auditors' Report

7

Consolidated Statement of Comprehensive Income

11

Consolidated Statement of Financial Position

12

Company Statement of Financial Position

13

Consolidated Statement of Changes in Equity

14

Company Statement of Changes in Equity

15

Consolidated Statement of Cash Flows

16

Notes to the Consolidated Financial Statements

17

DIRECTORS:

Mr S H Patel

Mrs V S Patel

REGISTERED OFFICE:

Sterling House

Fulbourne Road

Walthamstow

London

E17 4EE

REGISTERED NUMBER:

12655456 (England and Wales)

SENIOR STATUTORY AUDITOR:

Antony Kounnis FCCA

AUDITORS:

Christiansons Ltd

Chartered Certified Accountants

& Statutory Auditors

Sterling House

Fulbourne Road

Walthamstow

London

E17 4EE

INTRODUCTION

The directors present their strategic report for the period ending 31 March 2025.

PRINCIPAL ACTIVITIES AND BUSINESS REVIEW

The principle activity of the business throughout the year was operating retail pharmacies, located primarily in London area and conducting business via online website (hyperchem.co.uk). One of the Group undertakings also manages a large investment properties protfolio.

We are also developing an online presence with our website (livingbeauty.co.uk) and ecommerce stores on eBay and Amazon.

REVIEW OF BUSINESS

As directors of the group, we want to start by extending our sincere thanks to all our colleagues for their incredible efforts in the service of the patients and communities, in which community pharmacy plays a vital role. We are also grateful for their hard work in continuing to deliver our successful transformation strategy.

This strategy, to expand the pharmacy business that provides choice in healthcare to patients and consumer, has continue to resonate well and we are particularly pleased with our delivery in the revenue, this period. Our business model remained strong and continued to outperform under the economic and other barriers during this period.

Our business has faced many challenges from health strains, drop in rental revenue, drop in pharmacy footfall and government funding model which remains challenging.

Despite these barriers, we have wrote to improve the performance of the business, with interest of the community in mind. We continued to optimize our investment properties portfolio and overall business performance of the pharmacies.

As at 31 March 2025 we have 8 pharmacies operating in London and Norwich.

The company remains a holding company within the group structure.

FINANCIAL KEY PERFORMANCE INDICATORS

2025

Change of Turnover

2024

Change of Turnover

£

%

£

%

Sales

2,276,344

23.07

3,696,232

27.23

NHS Sales

7,592,359

76.93

9.879.049

72.77

Rental Income

567,090.00

5.75

741.014

5.46

The group has managed to achieve a gross profit of £3,041,921 which equates to a gross profit margin of 30.82%, from the operating pharmacies, this excludes rental income, as compare to industry average of 33.10%. Overall gross profit margin achieved by the business is 36.57% after including other operating income but before taking into account the administrative expenses as it remains competitive.

Many business within the same industry has witnessed a drop in footfall due to government regulation and other factors. Group operating margins were also impacted by the rising inflation.

The EBITDA was £703,480.

PRINCIPAL RISKS AND UNCERTAINTIES

The group is subject to a number of key risks. Risks are formally reviewed by its directors' and appropriate processes are put in place to monitor an mitigate them, with a risk management framework developed by the group undertakings.

REGULATION AND GOVERNMENT

Group operates in a highly regulated markets, and changes to the requirements and non-compliance, could have a negative impact on business performance.

- Pharmacy licencing arrangements

- Drug reimbursement levels

- Prescription processing requirements

- Traceability and storage

- Minimum wage requirements

- Data or privacy regulations

- Landlord and tenants act

The directors have kept a close eye and on the latest developments and continued their monitoring to minimizes the business disruption.

COMPETITION AND CHANGES IN CONSUMER BEHAVIOUR

Government reductions in pharmacy reimbursement in England have increased competition. This is a sector wide issue and we are working with relevant associations and the NHS to find the solution. But since April 2025, NHS has offered better rates which have help the pharmacies to absorb the extra employment and related costs due to increase in NMW and employer's insurance.

Changes and trends in patient and consumer behaviour, our key strategy is to differentiate ourselves by providing services, expert advice and care to our customers and patients.

PROCUREMENT AND HIRING TALENT

The group has faced increased costs in procurement and hiring talent, but we are trying to mitigate it by robust management, purchasing processes and controls.

FINANCIAL RISK MANAGEMENT

The group does not face an adverse credit or liquidity risk. Directors closely monitored all the credit risk and analytical procedures points to a stable business.

We as a group engage to build trust and understand the issues which are important to the local communities. Our focus is to support local causes and issues by creating job opportunities, helping environmental goals and engage communities through our pharmacies presence and social media.

We have an established partnerships with other societies to raise awareness and help local communities.

The directors' receives timely management information to act and safeguard the business interests. Which we will continue to apply.

ON BEHALF OF THE BOARD:

Mr S H Patel - Director

15 December 2025

The directors present their report with the financial statements of the company and the group for the year ended 31 March 2025.

PRINCIPAL ACTIVITY

Operating retail pharmacies and investing in properties.

DIVIDENDS

No interim dividend was paid during the year. The directors recommend a final dividend of £63.75 per share.

The total distribution of dividends for the year ended 31 March 2025 will be £ 255,000 .

FUTURE DEVELOPMENTS

Future developments of the business have been detailed in the strategic report.

DIRECTORS

The directors shown below have held office during the whole of the period from 1 April 2024 to the date of this report.

Mr S H Patel

Mrs V S Patel

STATEMENT OF DIRECTORS' RESPONSIBILITIES

The directors are responsible for preparing the Group Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the group and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:

-	select suitable accounting policies and then apply them consistently;

-	make judgements and accounting estimates that are reasonable and prudent;

-	prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's and the group's transactions and disclose with reasonable accuracy at any time the financial position of the company and the group and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The directors are responsible for the maintenance and integrity of the corporate and financial information included on the company's website.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS

So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the group's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the group's auditors are aware of that information.

AUDITORS

The auditors, Christiansons Ltd, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:

Mr S H Patel - Director

15 December 2025

Opinion

We have audited the financial statements of Avas Holdings Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 March 2025 which comprise the Consolidated Statement of Comprehensive Income, Consolidated Statement of Financial Position, Company Statement of Financial Position, Consolidated Statement of Changes in Equity, Company Statement of Changes in Equity, Consolidated Statement of Cash Flows and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

-	give a true and fair view of the state of the group's and of the parent company affairs as at 31 March 2025 and of the group's profit for the year then ended;

-	have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

-	have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and the parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The directors are responsible for the other information. The other information comprises the information in the Group Strategic Report and the Report of the Directors, but does not include the financial statements and our Auditors' Report thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

-	the information given in the Group Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and

-	the Group Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the group and the parent company and its environment obtained in the course of the audit, we have not identified material misstatements in the Group Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

-	adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or

-	the parent company financial statements are not in agreement with the accounting records and returns; or

-	certain disclosures of directors' remuneration specified by law are not made; or

-	we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the Statement of Directors' Responsibilities, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the group's and the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the group or the parent company or to cease operations, or have no realistic alternative but to do so.

Auditors' responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditors' Report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Irregularities, including fraud, represent instances of non-compliance with laws and regulations. We implement procedures aligned with our responsibilities, as outlined above, to detect material misstatements related to irregularities, including fraud. The effectiveness of our procedures in identifying such irregularities are detailed below.

We considered the nature of the company's industry and its control environment, and we reviewed the company’s policies and procedures concerning fraud and compliance with laws and regulations. Additionally, we consulted with management about their own identification and assessment of the risks associated with irregularities.

We gained an understanding of the legal and regulatory framework in which the company operates, identifying key laws and regulations that:

1. Have a direct effect on the determination of material amounts and disclosures in the financial

statements, such as the UK Companies Act, pensions legislation, and tax legislation.

2. Do not directly affect the financial statements but are fundamental to the company's ability to operate or to avoid significant penalties, such as regulatory solvency requirements and environmental regulations.

We also discussed with the audit engagement team, including relevant internal specialists such as those in tax, valuations, pensions, and IT, about the opportunities and incentives for fraud that may exist within the organization and how and where fraud could occur in the financial statements.

Because of the discussion, we identified the following high risk areas with the potential of significant high fraud risk. We have also described below our procedures to address these risk:

1. Revenue recognition, NHS sales have been tested with counter sales and also NHS statements, 3rd party statements, have been reconciled to the bank receipts and with the accounting system to ensure that NHS revenue completely recognised into the account.

2. As a norm for audits under ISAs (UK), we are also required to perform audit procedures to respond to the risk of management override. We responded by testing the appropriateness of the journal entries and other estimates in the financial statements, considering their potential bias and evaluated the business rational of significant transactions that are unusual or outside the normal course of the business.

We have also reviewed, the disclosures by testing the supporting documentation to assess the compliance with relevant laws and regulations which have a direct effect on the financial statements.

We have also performed analytical reviews alongside management enquiry to indemnify potential litigations or claims, and instance of non compliance with the laws and regulation.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Auditors' Report.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an Auditors' Report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Antony Kounnis FCCA (Senior Statutory Auditor)

for and on behalf of Christiansons Ltd

Chartered Certified Accountants

& Statutory Auditors

Sterling House

Fulbourne Road

Walthamstow

London

E17 4EE

15 December 2025

TURNOVER

9,868,703

13,575,281

Cost of sales

6,826,782

9,492,257

GROSS PROFIT

3,041,921

4,083,024

Administrative expenses

3,048,823

4,254,072

(6,902

)

(171,048

)

Other operating income

567,090

744,224

OPERATING PROFIT

560,188

573,176

Interest receivable and similar income

4,172

1,315

564,360

574,491

Interest payable and similar expenses

5

21,823

3,242

PROFIT BEFORE TAXATION

6

542,537

571,249

Tax on profit

7

152,034

169,822

PROFIT FOR THE FINANCIAL YEAR

390,503

401,427

OTHER COMPREHENSIVE INCOME

Increase in deferred tax provision

(200,473

)

(16,207

)

Income tax relating to other comprehensive income

-

-

OTHER COMPREHENSIVE INCOME FOR THE YEAR, NET OF INCOME TAX

(200,473

)

(16,207

)

TOTAL COMPREHENSIVE INCOME FOR THE YEAR

190,030

385,220

Profit attributable to:

Owners of the parent

390,503

401,427

Total comprehensive income attributable to:

Owners of the parent

190,030

385,220

FIXED ASSETS

Intangible assets

10

-

10,960

Tangible assets

11

914,655

470,534

Investments

12

-

-

Investment property

13

22,856,257

22,856,257

23,770,912

23,337,751

CURRENT ASSETS

Stocks

14

855,864

688,659

Debtors

15

2,469,320

2,433,814

Cash and cash equivalents

722,456

508,137

4,047,640

3,630,610

CREDITORS

Amounts falling due within one year

16

1,620,685

1,741,830

NET CURRENT ASSETS

2,426,955

1,888,780

TOTAL ASSETS LESS CURRENT LIABILITIES

26,197,867

25,226,531

CREDITORS

Amounts falling due after more than one year

17

(882,288

)

(41,639

)

PROVISIONS FOR LIABILITIES

20

(923,830

)

(728,173

)

NET ASSETS

24,391,749

24,456,719

CAPITAL AND RESERVES

Called up share capital

21

4,000

4,000

Share premium

22

11,798,000

11,798,000

Fair value reserve

22

4,066,300

4,266,773

Retained earnings

22

8,523,449

8,387,946

SHAREHOLDERS' FUNDS

24,391,749

24,456,719

The financial statements were approved by the Board of Directors and authorised for issue on 15 December 2025 and were signed on its behalf by:

Mr S H Patel - Director

FIXED ASSETS

Intangible assets

10

-

-

Tangible assets

11

-

-

Investments

12

4,000

4,000

Investment property

13

-

-

4,000

4,000

CURRENT ASSETS

Debtors

15

974,307

463,877

CREDITORS

Amounts falling due within one year

16

520,604

219,983

NET CURRENT ASSETS

453,703

243,894

TOTAL ASSETS LESS CURRENT LIABILITIES

457,703

247,894

CAPITAL AND RESERVES

Called up share capital

21

4,000

4,000

Retained earnings

22

453,703

243,894

SHAREHOLDERS' FUNDS

457,703

247,894

Company's profit for the financial year

464,809

518,007

The financial statements were approved by the Board of Directors and authorised for issue on 15 December 2025 and were signed on its behalf by:

Mr S H Patel - Director

Called up

Fair

share

Retained

Share

value

Total

capital

earnings

premium

reserve

equity

£

£

£

£

£

Balance at 1 October 2022

-

8,358,519

11,798,000

4,282,980

24,439,499

Changes in equity

Issue of share capital

4,000

-

-

-

4,000

Dividends

-

(372,000

)

-

-

(372,000

)

Total comprehensive income

-

401,427

-

(16,207

)

385,220

Balance at 31 March 2024

4,000

8,387,946

11,798,000

4,266,773

24,456,719

Changes in equity

Dividends

-

(255,000

)

-

-

(255,000

)

Total comprehensive income

-

390,503

-

(200,473

)

190,030

Balance at 31 March 2025

4,000

8,523,449

11,798,000

4,066,300

24,391,749

Called up

share

Retained

Total

capital

earnings

equity

£

£

£

Balance at 1 October 2022

-

97,887

97,887

Changes in equity

Issue of share capital

4,000

-

4,000

Dividends

-

(372,000

)

(372,000

)

Total comprehensive income

-

518,007

518,007

Balance at 31 March 2024

4,000

243,894

247,894

Changes in equity

Dividends

-

(255,000

)

(255,000

)

Total comprehensive income

-

464,809

464,809

Balance at 31 March 2025

4,000

453,703

457,703

Cash flows from operating activities

Cash generated from operations

25

352,793

379,099

Interest paid

(21,823

)

(2,064

)

Interest element of hire purchase payments paid

-

(1,178

)

Tax paid

(161,110

)

(2,397

)

Net cash from operating activities

169,860

373,460

Cash flows from investing activities

Purchase of tangible fixed assets

(572,281

)

(85,283

)

Interest received

4,172

1,315

Net cash from investing activities

(568,109

)

(83,968

)

Cash flows from financing activities

New loans in year

891,145

-

Capital repayments in year

(25,043

)

66,622

Amount withdrawn by directors

1,466

193

Cash flow adjustment

-

523,830

Equity dividends paid

(255,000

)

(372,000

)

Net cash from financing activities

612,568

218,645

Increase in cash and cash equivalents

214,319

508,137

Cash and cash equivalents at beginning of year

26

508,137

-

Cash and cash equivalents at end of year

26

722,456

508,137

1.	STATUTORY INFORMATION

Avas Holdings Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the General Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Significant judgements and estimates

The preparation of the group undertakings financial statements requires management to make judgements, estimates and assumption that affect the reported amounts of revenue, expenses, assets and liabilities and the disclosures at the reporting period end date. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

However, uncertainty about these assumptions and estimates could result in outcomes that requires a material adjustment to the carrying amount of the asset or liability affected in to the further periods.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revision to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, on in the period of the revision and future periods if the revision affects both current and future periods.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to the profit and loss account as incurred

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 0, is being amortised evenly over its estimated useful life of nil years.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Development costs are being amortised evenly over their estimated useful life of four years.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Fixtures and fittings

-

20% on reducing balance and 15% on reducing balance

Motor vehicles

-

25% on reducing balance

Computer equipment

-

33% on cost

Investment property

Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

According to the Companies Act 2006 all assets should be depreciated but investment properties have increase in value and as per director to show a true and fair view the investment properties should not be depreciated.

Depreciation itself is one of the method to work out the changes in value of the assets over a period of time but assets values can be affected by multiple factors and to accounts those factors no depreciation has been provided for investment properties instead they have been shown at thire fair value.

This is a departure from Companies Act 2006 but it is required by the Financial Reporting Standard 102, which will take precedent over the Companies Act 2006 requirenments to show a true and fair view.

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Consolidated Statement of Comprehensive Income, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The group operates a defined contribution pension scheme. Contributions payable to the group's pension scheme are charged to profit or loss in the period to which they relate.

Functional and presentation currency

The group undertakings, functional and presentational currency is GBP.

3.	EMPLOYEES AND DIRECTORS

Period

1.10.22

Year Ended

to

31.3.25

31.3.24

£

£

Wages and salaries

1,424,001

1,935,998

Social security costs

120,842

163,224

Other pension costs

21,105

26,724

1,565,948

2,125,946

The average number of employees during the year was as follows:

Period

1.10.22

Year Ended

to

31.3.25

31.3.24

Administrative staff

7

6

Pharmacies staff

51

54

58

60

4.	DIRECTORS' EMOLUMENTS

Period

1.10.22

Year Ended

to

31.3.25

31.3.24

£

£

Directors' remuneration

11,576

29,859

5.

INTEREST PAYABLE AND SIMILAR EXPENSES

Period

1.10.22

Year Ended

to

31.3.25

31.3.24

£

£

Interest payable

21,823

2,064

Hire purchase

-

1,178

21,823

3,242